Emalex Receives U.S. Patent for Orally Disintegrating Ecopipam Formulation Emalex Biosciences announced that the U.S. Patent and Trademark Office issued a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 receptor antagonist in development for the…
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system GE HealthCare integrates bkActiv™ with the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during…
Chevron Confirms Oil Discovery at Bandit Prospect in Gulf of America Chevron Corporation confirmed an oil discovery at the Bandit prospect in the Gulf of America, as announced by operator Occidental. The exploration well is located in Green Canyon Block…
Trinity Launches InsightsEDGE™ Digital Twins — Generative AI Unlocks Always-On Intelligence for Life Sciences Commercial Teams Trinity today announced broad launch of InsightsEDGE™ | Digital Twins, a market tested AI-solution that creates interactive virtual replicas of HCPs, patients, and payers, grounded…
Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics Thermo Fisher Scientific Inc. the world leader in serving science, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the…
Cloud Range Wins Gold in 2026 Cybersecurity Excellence Awards for Cyber Readiness and Validation Cloud Range, the industry-leading cyber readiness and simulation platform, has been named a Gold Award recipient in the Cyber Readiness and Validation category of the 2026…
CatalYm Doses First Patient in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Unresectable/Metastatic Hepatocellular Carcinoma CatalYm announced that the first patient has been dosed in the GDFATHER-HCC-01 trial The trial evaluates the company’s lead anti-GDF-15…
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from…
Swaney Group Capital and LongueVue Capital Invest in Apex Dental Laboratory Group Swaney Group Capital a Tampa-based private equity firm, in partnership with LongueVue Capital a New Orleans-based private equity firm, announced a strategic investment in Apex Dental Laboratory Group (“Apex”…
CTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance Deadline CTIS, Inc., with more than 30 years of experience in Health IT and clinical research informatics expertise for government and industry clients, today announced the…
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right Aurinia Pharmaceuticals Inc. a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs, announced…
LIB Therapeutics Announces Results from Presentations on LEROCHOL® at 2026 American College of Cardiology meeting in New Orleans March 28-29, 2026 LIB Therapeutics Inc. a privately-held, biopharmaceutical company with a recently approved novel, monthly, small dose third-generation PCSK9 inhibitor, LEROCHOL® (lerodalcibep-liga), announced…